Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus.
Sutter
G
G
Institute of Molecular Virology, GSF-Centre for Environmental and Health Research, Oberschleissheim, Germany.
Moss
B
B
D000818:Animals; D005069:Evaluation Studies as Topic; D005822:Genetic Vectors / Q000302:isolation & purification; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000235:genetics / Q000302:isolation & purification; D051379:Mice; D011995:Recombination, Genetic; D012449:Safety; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000235:genetics / Q000302:isolation & purification; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000235:genetics* / Q000302:isolation & purification; D014616:Vaccinia virus / Q000235:genetics*
D007252:Influenza Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic